Article Versions Notes

Vaneev AN, Kost OA, Eremeev NL, Beznos OV, Alova AV, Gorelkin PV, Erofeev AS, Chesnokova NB, Kabanov AV, Klyachko NL. Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases. Biomedicines. 2021; 9(4):396. https://doi.org/10.3390/biomedicines9040396

Vaneev, Alexander N., Olga A. Kost, Nikolay L. Eremeev, Olga V. Beznos, Anna V. Alova, Peter V. Gorelkin, Alexander S. Erofeev, Natalia B. Chesnokova, Alexander V. Kabanov, and Natalia L. Klyachko. 2021. "Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases" Biomedicines 9, no. 4: 396. https://doi.org/10.3390/biomedicines9040396

Vaneev, A. N., Kost, O. A., Eremeev, N. L., Beznos, O. V., Alova, A. V., Gorelkin, P. V., Erofeev, A. S., Chesnokova, N. B., Kabanov, A. V., & Klyachko, N. L. (2021). Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases. Biomedicines, 9(4), 396. https://doi.org/10.3390/biomedicines9040396